Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Hikal Limited ( (IN:HIKAL) ) has provided an update.
Hikal Limited has disclosed to the stock exchanges that promoter Sugandha Hiremath and persons acting in concert have made no encumbrances on their shareholding in the company for the financial year ended March 31, 2026. The confirmation under SEBI’s takeover regulations signals that the promoters’ stake remains unpledged, providing reassurance to investors about promoter confidence and financial stability, and supporting transparency in the company’s ownership structure.
More about Hikal Limited
Hikal Limited operates in the pharmaceuticals and specialty chemicals sector, supplying active pharmaceutical ingredients and crop protection products to global life sciences companies. The firm serves regulated markets and works closely with multinational clients, positioning itself as a critical partner in outsourced development and manufacturing.
Average Trading Volume: 61,758
Technical Sentiment Signal: Sell
Current Market Cap: 20.35B INR
Learn more about HIKAL stock on TipRanks’ Stock Analysis page.